Cochrane Abstracts
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Second or Third Additional Chemotherapy Drug for Non-small Cell Lung Cancer in Patients With Advanced Disease: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non_small_cell_lung_cancer_in_patients_with_advanced_disease:_Cochrane_systematic_review.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non_small_cell_lung_cancer_in_patients_with_advanced_disease:_Cochrane_systematic_review. Accessed January 22, 2025.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non_small_cell_lung_cancer_in_patients_with_advanced_disease:_Cochrane_systematic_review
Second or Third Additional Chemotherapy Drug for Non-small Cell Lung Cancer in Patients With Advanced Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non_small_cell_lung_cancer_in_patients_with_advanced_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
ID - 434883
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non_small_cell_lung_cancer_in_patients_with_advanced_disease:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
